CA1119591A - Prostane derivatives - Google Patents

Prostane derivatives

Info

Publication number
CA1119591A
CA1119591A CA000291953A CA291953A CA1119591A CA 1119591 A CA1119591 A CA 1119591A CA 000291953 A CA000291953 A CA 000291953A CA 291953 A CA291953 A CA 291953A CA 1119591 A CA1119591 A CA 1119591A
Authority
CA
Canada
Prior art keywords
trans
oxo
cis
radical
pentanor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000291953A
Other languages
English (en)
French (fr)
Inventor
Keith H. Gibson
Edward R. H. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA1119591A publication Critical patent/CA1119591A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
CA000291953A 1976-12-08 1977-11-29 Prostane derivatives Expired CA1119591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB51196/76 1976-12-08
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Publications (1)

Publication Number Publication Date
CA1119591A true CA1119591A (en) 1982-03-09

Family

ID=10459023

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000291953A Expired CA1119591A (en) 1976-12-08 1977-11-29 Prostane derivatives

Country Status (14)

Country Link
JP (1) JPS5371060A (enExample)
AU (1) AU3104477A (enExample)
BE (1) BE861652A (enExample)
CA (1) CA1119591A (enExample)
DE (1) DE2754741A1 (enExample)
DK (1) DK548177A (enExample)
FR (1) FR2373538A1 (enExample)
GB (1) GB1550399A (enExample)
IE (1) IE46170B1 (enExample)
IT (1) IT1089433B (enExample)
NL (1) NL7713587A (enExample)
NZ (1) NZ185822A (enExample)
SE (1) SE7713895L (enExample)
ZA (1) ZA777059B (enExample)

Also Published As

Publication number Publication date
AU3104477A (en) 1979-06-07
ZA777059B (en) 1978-08-30
FR2373538B1 (enExample) 1981-07-10
JPS5371060A (en) 1978-06-24
BE861652A (fr) 1978-06-08
IE46170B1 (en) 1983-03-09
SE7713895L (sv) 1978-06-09
NL7713587A (nl) 1978-06-12
DK548177A (da) 1978-06-09
DE2754741A1 (de) 1978-06-15
IE46170L (en) 1978-06-08
FR2373538A1 (fr) 1978-07-07
NZ185822A (en) 1979-03-16
GB1550399A (en) 1979-08-15
IT1089433B (it) 1985-06-18

Similar Documents

Publication Publication Date Title
US4304907A (en) Bicyclo lactone intermediates for prostaglandin analogs
US4024179A (en) Substituted ω-pentanorprostaglandins
CA1059122A (en) 2-descarboxy-2 (tetrazol-5-yl)-11-desoxy-15-substituted ?-pentanorprostaglandins
US3883513A (en) Tetrazoyl derivatives of naturally occurring prostaglandins
US3962293A (en) 13,14-Dihydro-16-fluoro prostaglandin F1
EP0159784B1 (en) Carbacyclin analogues
US3953502A (en) Cyclopentane derivatives
US4004020A (en) Novel prostanoic acid derivatives and process for the preparation thereof
US3984424A (en) P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
US3984400A (en) 11-Desoxy-16-aryl-ω-tetranorprostaglandins
US4321275A (en) Method of inducing luteolysis using 16-aryloxy-17,18,19,20-tetranor-prostanoic acid derivatives
US4105854A (en) Prostanoic acid derivatives
CA1119591A (en) Prostane derivatives
GB2041368A (en) Prostaglandin analogues
DE68910774T2 (de) Cyclopentanheptencarbonsäurederivate und Verfahren zu ihrer Herstellung.
JPS5846510B2 (ja) 13,14−デヒドロ−11−デオキシ−プロスタグランジン及びその製造法
US4004021A (en) Cyclopentane derivatives
US4115580A (en) 3,4-Epoxy-cyclopenta-1,2-diyl prostanes
US4074044A (en) Cyanoprostaglandins
US3953466A (en) 4(Tetrazol-5-yl)-butyltriphenylphosphonium halide compounds
US4096337A (en) Prostane derivatives
US3969376A (en) 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
US3969381A (en) 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3969379A (en) 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
US3873598A (en) 4,5,10,13 prostatetraenoic acid derivatives

Legal Events

Date Code Title Description
MKEX Expiry